Sound fa­mil­iar? Chi­na/US biotech hy­brid lands rights to can­cer drugs, cash and a team of de­vel­op­ment vets to launch On­colo­gie

Look­ing for a new and sud­den­ly pop­u­lar busi­ness mod­el?

An­oth­er transpa­cif­ic biotech has launched with the back­ing of an emerg­ing group of ven­ture in­vestors in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER